Asymptomatic malignant pleural effusion: to observe or to manage.
作者信息
Keshishyan Sevak, Harris Kassem
机构信息
Division of Pulmonary, Critical Care, and Sleep Medicine, Interventional Pulmonology Section, Westchester Medical Center, Valhalla, NY, USA.
出版信息
J Thorac Dis. 2017 Sep;9(Suppl 10):S1146-S1147. doi: 10.21037/jtd.2017.06.52.
Abstract
摘要
相似文献
1
Asymptomatic malignant pleural effusion: to observe or to manage.无症状恶性胸腔积液：观察还是处理。
J Thorac Dis. 2017 Sep;9(Suppl 10):S1146-S1147. doi: 10.21037/jtd.2017.06.52.
2
Managing malignant pleural effusion with an indwelling pleural catheter: factors associated with spontaneous pleurodesis.使用留置胸膜导管治疗恶性胸腔积液：与自发性胸膜固定术相关的因素。
Hong Kong Med J. 2016 Aug;22(4):334-40. doi: 10.12809/hkmj154673. Epub 2016 Jun 3.
3
Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study.医学胸腔镜引导下腔内多西紫杉醇治疗非小细胞肺癌恶性胸腔积液的疗效：一项初步研究。
Thorac Cancer. 2019 Oct;10(10):1885-1892. doi: 10.1111/1759-7714.13158. Epub 2019 Aug 6.
4
Malignant melanoma presenting as an isolated pleural effusion.以孤立性胸腔积液为表现的恶性黑色素瘤。
Monaldi Arch Chest Dis. 2011 Jun;75(2):138-40. doi: 10.4081/monaldi.2011.228.
5
Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion.重复胸腔穿刺术对恶性胸腔积液中液体特征、细胞因子及纤溶活性的影响。
Chest. 2003 Apr;123(4):1188-95. doi: 10.1378/chest.123.4.1188.
6
CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.恶性胸腔积液中的CD4+CD25+调节性T淋巴细胞
Am J Respir Crit Care Med. 2005 Dec 1;172(11):1434-9. doi: 10.1164/rccm.200504-588OC. Epub 2005 Sep 8.
7
Pleural effusion in an asymptomatic patient. Spectrum and frequency of causes and management considerations.
Chest. 1990 Jan;97(1):192-6. doi: 10.1378/chest.97.1.192.
8
Indwelling pleural catheters for malignant pleural effusion.
Int J Palliat Nurs. 2015 Jun;21(6):266, 268-70. doi: 10.12968/ijpn.2015.21.6.266.
9
Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions.恶性胸腔积液治疗性胸腔穿刺术后无症状性液气胸。
AJR Am J Roentgenol. 1998 Apr;170(4):943-6. doi: 10.2214/ajr.170.4.9530040.
10
Malignant pleural diseases.恶性胸膜疾病
Monaldi Arch Chest Dis. 2000 Feb;55(1):17-9.
引用本文的文献
1
A Rapidly Enlarging Asymptomatic Parapneumonic Effusion: A Case Report.一例迅速增大的无症状类肺炎性胸腔积液：病例报告
Cureus. 2024 Jan 26;16(1):e52986. doi: 10.7759/cureus.52986. eCollection 2024 Jan.
2
Malignant Pleural Effusions: Updates in Diagnosis and Management.恶性胸腔积液：诊断与治疗的新进展
Life (Basel). 2022 Dec 31;13(1):115. doi: 10.3390/life13010115.
3
Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.胸腔镜滑石粉注射治疗恶性胸腔积液的并发症：荟萃分析。
J Cardiothorac Surg. 2021 May 4;16(1):125. doi: 10.1186/s13019-021-01475-1.
4
Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis.滑石粉胸膜固定术治疗恶性胸腔积液：系统评价和荟萃分析。
Gen Thorac Cardiovasc Surg. 2021 May;69(5):832-842. doi: 10.1007/s11748-020-01549-2. Epub 2020 Nov 22.
本文引用的文献
1
Comparing approaches to the management of malignant pleural effusions.恶性胸腔积液管理方法的比较
Expert Rev Respir Med. 2017 Apr;11(4):273-284. doi: 10.1080/17476348.2017.1300532. Epub 2017 Mar 8.
2
Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions.胸膜疾病的争议：用于恶性胸腔积液的留置胸膜导管与胸膜固定术
J Thorac Dis. 2015 Jun;7(6):1052-7. doi: 10.3978/j.issn.2072-1439.2015.01.51.
3
Malignant pleural effusions: a review.恶性胸腔积液：综述。
Clin Chest Med. 2013 Sep;34(3):459-71. doi: 10.1016/j.ccm.2013.05.004. Epub 2013 Jul 23.
4
Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion.改良 Borg 量表和视觉模拟量表呼吸困难评分预测恶性胸腔积液引流后再干预的比较。
Support Care Cancer. 2013 Nov;21(11):3109-16. doi: 10.1007/s00520-013-1895-3. Epub 2013 Jul 11.
5
Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.恶性胸腔积液的管理：英国胸科学会胸膜疾病指南2010
Thorax. 2010 Aug;65 Suppl 2:ii32-40. doi: 10.1136/thx.2010.136994.
6
Emerging paradigms in the management of malignant pleural effusions.恶性胸腔积液管理的新兴模式
Respir Med. 2008 Jul;102(7):939-48. doi: 10.1016/j.rmed.2008.01.022. Epub 2008 Mar 19.
7
Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer.胸水表皮生长因子受体（EGFR）突变检测对预测吉非替尼治疗肺癌患者临床疗效的价值
Int J Cancer. 2006 Nov 15;119(10):2353-8. doi: 10.1002/ijc.22190.
8
Effects of pleural effusion on respiratory function.胸腔积液对呼吸功能的影响。
Can Respir J. 2004 Oct;11(7):499-503. doi: 10.1155/2004/496901.
9
Management of malignant pleural effusions.恶性胸腔积液的管理
Respirology. 2004 Jun;9(2):148-56. doi: 10.1111/j.1440-1843.2004.00566.x.
10
Management of malignant pleural effusions.恶性胸腔积液的管理
Am J Respir Crit Care Med. 2000 Nov;162(5):1987-2001. doi: 10.1164/ajrccm.162.5.ats8-00.
Zotero 插件